Literature DB >> 7737657

Assessment of cell proliferation in pathology--what next?

P A Hall1, P J Coates.   

Abstract

This brief overview outlines recent progress in our understanding of the regulation of cell population size, focusing on some important developments in cell cycle control and the recognition of the importance of growth arrest and cell death. Histopathologists, and others with an interest in tissue architecture, have much to offer to those who study the biochemical and molecular processes of proliferation, growth arrest and cell death, and these processes are unlikely to be understood simply by analysis of in vitro systems and cell lines. Such biochemical and histological information may well feed back into clinical medicine in terms of new approaches and techniques, new reagents and new paradigms. With regard to the application of measures of proliferation, growth arrest and cell death as prognostic factors or other diagnostic tools, we are sceptical. Methods for assessing cell proliferation seem unlikely to be implemented widely in practice since there is little direct evidence that they are really an improvement on conventional histological assessment, optimally employed. But, there again, we may be proved wrong! In particular, it may be that, if carefully employed, assays that integrate information about death, growth arrest and proliferation may be clinically valuable.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737657     DOI: 10.1111/j.1365-2559.1995.tb00639.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

1.  Apoptosis in cervical squamous carcinoma: predictive value for survival following radiotherapy.

Authors:  J R Paxton; B S Bolger; A Armour; R P Symonds; J H Mao; R A Burnett
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

2.  Ki-67 expression in early prostate cancer and associated pathological lesions.

Authors:  M R Feneley; M P Young; C Chinyama; R S Kirby; M C Parkinson
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

3.  Ki-67 labeling is correlated with the time to recurrence in primary glioblastomas.

Authors:  Roland Schröder; Klaus D Feisel; Ralf-Ingo Ernestus
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

4.  Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma.

Authors:  A E Pinto; S André; T Pereira; S Nóbrega; J Soares
Journal:  J Clin Pathol       Date:  2001-07       Impact factor: 3.411

5.  Prognostic significance of the proliferative activity in neuroblastoma.

Authors:  P Rudolph; T Lappe; B Hero; F Berthold; R Parwaresch; D Harms; D Schmidt
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

6.  Ki-67, oestrogen receptor, and progesterone receptor proteins in the human rete ovarii and in endometriosis.

Authors:  M S Khan; A R Dodson; M K Heatley
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

7.  The Pathology of Medullary Carcinoma of the Thyroid: Review of the Literature and Personal Experience on 62 Cases.

Authors:  Mauro Papotti; Daniela Sambataro; Carla Pecchioni; Gianni Bussolati
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

8.  Vitamin E supplementation in chemical colorectal carcinogenesis: a two-edged knife.

Authors:  Celia Cohen; João Felipe Rito Cardoso; Sergio Britto Garcia; Helio Vannucchi
Journal:  Nutrients       Date:  2014-08-13       Impact factor: 5.717

9.  Expression and clinical significance of the proliferation marker minichromosome maintenance protein 2 (Mcm2) in diffuse astrocytomas WHO grade II.

Authors:  Tove Lind-Landström; Rosilin K Varughese; Stein Sundstrøm; Sverre H Torp
Journal:  Diagn Pathol       Date:  2013-04-24       Impact factor: 2.644

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.